PapersFlow Research Brief
Cardiac pacing and defibrillation studies
Research Guide
What is Cardiac pacing and defibrillation studies?
Cardiac pacing and defibrillation studies is a cluster of research focusing on Cardiac Resynchronization Therapy (CRT) for managing heart failure in patients with left ventricular dysfunction and ventricular arrhythmias, including implantable cardioverter-defibrillators, echocardiography-guided lead placement, remote monitoring, and effects on dyssynchrony and sudden cardiac death.
This field encompasses 87,956 works on CRT, implantable cardioverter-defibrillators, and related therapies for heart failure. Studies address ventricular arrhythmias, left ventricular dysfunction, echocardiography, pacemaker therapy, remote monitoring, dyssynchrony, and sudden cardiac death. Growth data over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Cardiac Resynchronization Therapy Optimization
This sub-topic investigates multipoint pacing, His-bundle pacing, and left bundle branch area pacing to maximize synchrony in non-responders. Researchers use ECG morphology, strain imaging, and machine learning for patient selection and programming.
Implantable Cardioverter-Defibrillator Primary Prevention
This sub-topic evaluates ICD implantation in heart failure based on LVEF, QRS duration, and novel risk scores beyond MADIT/SCD-HeFT criteria. Researchers study wearable device screening and shared decision-making frameworks.
CRT-D vs CRT-P Device Selection
This sub-topic compares defibrillator vs pacemaker-only CRT in heart failure, weighing arrhythmia risk against infection and cost. Researchers analyze DANISH/REVERSE-IT trials for appropriate therapy selection.
Echocardiography-Guided Lead Placement
This sub-topic employs speckle-tracking echocardiography to target latest mechanical delay sites for LV lead implantation. Researchers validate quadripolar leads and robotic delivery for anatomical optimization.
Remote Monitoring in CRT Patients
This sub-topic assesses implantable device diagnostics for early detection of worsening heart failure, arrhythmias, and lead dysfunction. Researchers develop risk prediction algorithms integrating daily transmissions with biomarkers.
Why It Matters
These studies guide clinical management of heart failure patients at risk of sudden cardiac death through CRT and defibrillators. "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction" by Moss et al. (2002) demonstrated improved survival in patients with prior myocardial infarction and advanced left ventricular dysfunction. "Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure" by Bardy et al. (2005) showed single-lead, shock-only ICD therapy reduced overall mortality by 23 percent in NYHA class II or III CHF patients with LVEF of 35 percent or less. "The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure" by Cleland et al. (2005) found CRT improves symptoms, quality of life, reduces complications, and lowers death risk beyond pharmacologic therapy. "Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure" by Bristow et al. (2004) reported CRT decreases combined risk of death or hospitalization, with defibrillator addition significantly reducing mortality.
Reading Guide
Where to Start
"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure" by McDonagh et al. (2021) as it provides the most recent comprehensive clinical recommendations synthesizing pacing and defibrillation evidence with 11,747 citations.
Key Papers Explained
Ponikowski et al. (2021 corrigendum) corrects the 2021 ESC guidelines by McDonagh et al. (2021), which build on Ponikowski et al. (2016) by integrating evidence from trials like Moss et al. (2002) on prophylactic defibrillators and Cleland et al. (2005) on CRT morbidity reduction. Earlier guidelines by McMurray et al. (2012) laid foundations later expanded by Bardy et al. (2005) and Bristow et al. (2004), showing ICD and CRT survival benefits. These connect through progressive guideline updates incorporating NEJM trial results.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize refining CRT for left ventricular dysfunction via echocardiography and remote monitoring, targeting dyssynchrony and arrhythmia prevention. Focus persists on guideline implementation from Ponikowski et al. (2016) and McDonagh et al. (2021), addressing ventricular arrhythmias in heart failure.
Papers at a Glance
Frequently Asked Questions
What is the role of implantable cardioverter-defibrillators in heart failure?
Implantable cardioverter-defibrillators improve survival in heart failure patients with reduced ejection fraction. Moss et al. (2002) showed prophylactic implantation benefits patients with prior myocardial infarction and advanced left ventricular dysfunction. Bardy et al. (2005) found ICD therapy reduces mortality by 23 percent compared to amiodarone in NYHA class II or III CHF with LVEF ≤35 percent.
How does cardiac resynchronization therapy affect heart failure outcomes?
CRT improves symptoms, quality of life, reduces complications, and lowers death risk in heart failure patients with dyssynchrony. Cleland et al. (2005) demonstrated these benefits add to standard pharmacologic therapy. Bristow et al. (2004) showed CRT decreases death or hospitalization risk, further reduced by combining with defibrillators.
What do ESC guidelines recommend for heart failure management?
ESC guidelines cover diagnosis and treatment of acute and chronic heart failure, including pacing and defibrillation. McDonagh et al. (2021) and Ponikowski et al. (2016) provide recommendations developed by ESC Task Forces. Earlier versions by McMurray et al. (2012) collaborated with the Heart Failure Association.
What patient groups benefit from prophylactic defibrillators?
Patients with myocardial infarction, reduced ejection fraction, and ventricular arrhythmias benefit from prophylactic defibrillators. Moss et al. (2002) established improved survival in those with advanced left ventricular dysfunction. This applies to heart failure with LVEF ≤35 percent per Bardy et al. (2005).
How has research on CRT evolved in guidelines?
ESC guidelines have iteratively incorporated CRT evidence from studies like Cleland et al. (2005) and Bristow et al. (2004). Ponikowski et al. (2021 corrigendum), McDonagh et al. (2021), and Ponikowski et al. (2016) reflect updates on heart failure management including CRT.
Open Research Questions
- ? How can echocardiography-guided lead placement optimize CRT response rates in non-responders?
- ? What biomarkers best predict sudden cardiac death risk despite ICD implantation?
- ? Which remote monitoring parameters most accurately detect dyssynchrony progression in CRT patients?
- ? How do ventricular arrhythmia patterns influence defibrillator programming efficacy?
- ? What long-term effects of CRT on left ventricular remodeling remain unquantified in diverse populations?
Recent Trends
The field maintains 87,956 works with no specified 5-year growth rate.
Highly cited ESC guidelines continue dominating, with Ponikowski et al. (2021 corrigendum, 19,535 citations) and McDonagh et al. (2021, 11,747 citations) as top papers.
No recent preprints or news coverage available in the last 6-12 months indicates steady reliance on established studies like Moss et al. and Bardy et al. (2005).
2002Research Cardiac pacing and defibrillation studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac pacing and defibrillation studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers